|Industry||Clinical Development and Biopharma|
|Slogan||The Human Data Science Company|
|Headquarters||Danbury, CT and Durham, NC|
|Key people|| Dennis Gillings, Founder |
Ari Bousbib, Chairman and CEO
|Number of employees||~ 55,000|
|Related Certifications||Certificate in Current Pharmacovigilance Regulatory Landscape|
IQVIA is a multinational company which is formed through the merger of IMS Health and Quintiles and it was formerly known as QuintilesIMS. It provides integrated information and technology-enabled healthcare services and operates through three segments: Integrated engagement services, research, development and commercial solutions, which enable life sciences companies to innovate with confidence, maximize opportunities, and drive human health outcomes forward. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. IQVIA is headquartered in Durham, NC, and Danbury CT, with running operations in more than 100 countries and with more than 55,000 employees worldwide. 
It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about exploring a new path to better health outcomes via Human Data Science. It’s about harnessing the power of the IQVIA CORE™ to channel the insights, commercial and scientific depth, and executional expertise that drive maximum value for our customers.By applying data science to the continuous advancement of human science, decisions become more precise. More relevant. Even more creative
They provide solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.
It provides actionable solutions by tapping into the power of the IQVIA CORE™:
• Domain Expertise. Institutional knowledge and domain expertise across diseases, geographies and scientific methods
• Advanced Analytics. Faster, more precise decision-making generated by advanced analytics designed for healthcare
• Unparalleled Data. One of the world’s largest curated healthcare data sources with innovative privacy protections
• Transformative Technology. Leading technologies to provide real-time access to operations-critical information
Human Data Science is a new way for life sciences companies to rethink the future of healthcare. By applying data science to the continuous advancement of human science, decisions become more precise. More relevant. Even more creative. To learn more, visit www.IQVIA.com
In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.
Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990, and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.
In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.
Quintiles went public in 1997 and completed a successful secondary stock offering.
Over 2016 concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health becoming QuintilesIMS.
In Dec 2016, it acquired Q2 Metrics Inc a business intelligence company in the healthcare sector.
In November 2017, the company adopted the new name of IQVIA and changed its ticker symbol from Q to IQV. Its shares will continue to trade on the NYSE.
FORTUNE World's Most Admired Companies 2018
Selected as one of the 2018 FORTUNE “World’s Most Admired Companies®," IQVIA ranked #1 Healthcare: Pharmacy and other services.*
*From FORTUNE Magazine, February 1, 2018 ©2018 Time Inc. FORTUNE and The World’s Most Admired Companies are registered trademarks of Time Inc. and are used under license. FORTUNE and Time Inc. are not affiliated with, and do not endorse products or services of, IQVIA.
Top 5 Recent Tweets
|January 26, 2022||JDruryPartners||IQVIA adds Leslie Wims Morris (Managing Director/Head-Corporate Development-Consumer & Community Banking, JPMorgan… https://t.co/IUn9Umd6Ix|
|January 25, 2022||IQVIA_Biotech||Define the value of your asset, create a differentiate value story, and drive investor and partnering discussions f… https://t.co/6qJcwn2rAD|
|January 25, 2022||iqviacompliance||Traditional collection of Adverse Event information has been lengthy and costly. IQVIA’s Vigilance Collect speeds u… https://t.co/5s3fx1ZUc7|
|January 25, 2022||IQVIA_Tech||When enterprises struggle to understand #insights, it limits their ability to measure, optimize and act strategical… https://t.co/w1GhhUzBY0|